🇺🇸 FDA
Patent

US 8513302

Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids

granted A61KA61K31/17A61K31/355

Quick answer

US patent 8513302 (Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids) held by The Regents of the University of California expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/17, A61K31/355, A61K31/70, A61P